Valproic acid as anti-cancer drug
- PMID: 18045192
Valproic acid as anti-cancer drug
Abstract
The short chain fatty acid valproic acid (VPA, 2-propylpetanoic acid) is approved for the treatment of epilepsia, bipolar disorders and migraine and clinically used for schizophrenia. In 1999, the first clinical anti-cancer trial using VPA was initiated. Currently, VPA is examined in numerous clinical trials for different leukaemias and solid tumour entities. In addition to clinical assessment, the experimental examination of VPA as anti-cancer drug is ongoing and many questions remain unanswered. Although other mechanisms may also contribute to VPA-induced anti-cancer effects, inhibition of histone deacetylases appears to play a central role. This review focuses on recent developments regarding the anti-cancer activity of VPA.
Similar articles
-
Structure-function studies for the panacea, valproic acid.Biochem Soc Trans. 2009 Oct;37(Pt 5):1126-32. doi: 10.1042/BST0371126. Biochem Soc Trans. 2009. PMID: 19754465 Review.
-
New perspectives of valproic acid in clinical practice.Expert Opin Investig Drugs. 2013 Dec;22(12):1535-47. doi: 10.1517/13543784.2013.853037. Epub 2013 Oct 28. Expert Opin Investig Drugs. 2013. PMID: 24160174 Review.
-
New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?Curr Opin Neurol. 2003 Apr;16(2):203-11. doi: 10.1097/01.wco.0000063774.81810.30. Curr Opin Neurol. 2003. PMID: 12644750 Review.
-
Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.J Affect Disord. 2006 Oct;95(1-3):69-78. doi: 10.1016/j.jad.2006.04.030. Epub 2006 Jun 15. J Affect Disord. 2006. PMID: 16780960 Review.
-
Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors.Cancer Treat Rev. 2008 May;34(3):206-22. doi: 10.1016/j.ctrv.2007.11.003. Epub 2008 Jan 15. Cancer Treat Rev. 2008. PMID: 18226465 Review.
Cited by
-
Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells.Interdiscip Toxicol. 2009 Sep;2(3):205-10. doi: 10.2478/v10102-009-0019-x. Epub 2009 Sep 28. Interdiscip Toxicol. 2009. PMID: 21217856 Free PMC article.
-
The prince and the pauper. A tale of anticancer targeted agents.Mol Cancer. 2008 Oct 23;7:82. doi: 10.1186/1476-4598-7-82. Mol Cancer. 2008. PMID: 18947424 Free PMC article. Review.
-
Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response.Mol Neurobiol. 2018 Aug;55(8):6816-6833. doi: 10.1007/s12035-018-0895-1. Epub 2018 Jan 19. Mol Neurobiol. 2018. PMID: 29349577
-
Unconditioned and conditioned anxiolytic effects of Sodium Valproate on flavor neophobia and fear conditioning.PLoS One. 2023 Jul 7;18(7):e0279511. doi: 10.1371/journal.pone.0279511. eCollection 2023. PLoS One. 2023. PMID: 37418453 Free PMC article.
-
Time to focus on brain tumor-related epilepsy trials.Neurooncol Pract. 2014 Sep;1(3):123-133. doi: 10.1093/nop/npu010. Neurooncol Pract. 2014. PMID: 31386030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
